The development of RNA technologies demands accurate assessment of transcript size and heterogeneity. Here, authors report a nanopore-based approach to study full-length RNA transcripts at the single-molecule level, identify premature transcription termination and study rolling-circle transcription.
In August of 2021, my firm made a very bold prediction that Nvidia will surpass Apple in valuation.
We look at why Nvidia has been able to surpass every FAANG except Apple, and why it’s inevitable that it becomes the world’s most valuable company in the next 2.5 years.
The online retail giant’s place in the corporate firmament is cemented with membership in the Dow.
Tech companies can’t get enough of Nvidia, the chipmaker powering the AI revolution. Meet the CEO charting the company’s future—and the entire industry’s along with it.
MIT engineers achieve a breakthrough in electronics with fully 3D-printed solenoids, revolutionizing manufacturing and democratizing access to technology.
MIT engineers pioneer 3D-printed solenoids, unlocking new possibilities in electronics manufacturing.
In a vacuum like space, the speed of light is just over 186,280 miles per second. Scientists have now shown it’s possible to slow it down to zero miles per second without sacrificing its brightness, regardless of its frequency or bandwidth.
ToDo.
Token downsampling for efficient generation of high-resolution images.
Join the discussion on this paper page.
Scripps Research scientists have developed an antibody that can block the effects of lethal toxins in the venoms of a wide variety of snakes found throughout Africa, Asia and Australia.
The antibody, which protected mice from the normally deadly venom of snakes including black mambas and king cobras, is described in Science Translational Medicine. The new research used forms of the toxins produced in the laboratory to screen billions of different human antibodies and identify one that can block the toxins’ activity. It represents a large step toward a universal antivenom that would be effective against the venom of all snakes.
“This antibody works against one of the major toxins found across numerous snake species that contribute to tens of thousands of deaths every year,” says senior author Joseph Jardine, Ph.D., assistant professor of immunology and microbiology at Scripps Research. “This could be incredibly valuable for people in low-and middle-income countries that have the largest burden of deaths and injuries from snakebites.”
